New Biocytogen and Abl collaboration focuses on bispecific antibody-drug conjugates
March 25, 2024
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. and Abl Bio Inc. have established a collaboration to develop new bispecific antibody-drug conjugates (bsADCs).